These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 339985)

  • 1. The modified Makari skin test in urology--is it significant?
    Munson KW; Tee DE
    Br J Urol; 1977; 49(7):569-73. PubMed ID: 339985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the Makari test in urological malignancies.
    Munson KW; Tee DE
    Br J Urol; 1977 Nov; 49(6):457-61. PubMed ID: 338088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the modified Makari skin test in minimal residual malignant disease.
    Tee DE
    Recent Results Cancer Res; 1979; 67():93-6. PubMed ID: 377433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Makari skin test in follow-up of bladder-cancer patients.
    Tee DE; Munson KW
    Lancet; 1977 Sep; 2(8036):480-1. PubMed ID: 70690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Clinical experience with the Makari tumour skin test.
    Tee DE
    Br J Cancer; 1974 Aug; 30(2):186-7. PubMed ID: 4607925
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vivo testing of cell-mediated immunity in urology].
    Heinz A; Hallwachs O
    Onkologie; 1987 Jun; 10(3 Suppl):8-11. PubMed ID: 3309763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy: A paradigm shift in the treatment of advanced urologic cancers.
    Gill DM; Agarwal N
    Urol Oncol; 2017 Dec; 35(12):676-677. PubMed ID: 29054496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the Makari tumour skin test.
    Tee DE
    Br J Cancer Suppl; 1973 Aug; 1():187-97. PubMed ID: 4613375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the Makari tumor skin test in 470 patients.
    Tee DE
    J Am Geriatr Soc; 1972 Jul; 20(7):305-11. PubMed ID: 4556849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Skin tests in studying secondary cellular immunity. Their use and value in urological cancers. 154 tests on 107 patients].
    Lachand AT; Martin-Mondière C
    J Urol Nephrol (Paris); 1978; 84(10-11):787-93. PubMed ID: 745260
    [No Abstract]   [Full Text] [Related]  

  • 11. Open clinical uro-oncology trials in Canada.
    Winquist E; Rodrigues G
    Can J Urol; 2012 Dec; 19(6):6587-91. PubMed ID: 23228299
    [No Abstract]   [Full Text] [Related]  

  • 12. TAF-test: a tumor diagnosis device in oncologic urology.
    Siracusano F; Tarro G; Biviano D; Flaminio G; Saladino I; Piccolo A
    Cancer; 1982 Nov; 50(10):2215-7. PubMed ID: 6181864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult urologic sarcoma: experience during 2 decades.
    Froehner M; Schober RR; Koch R; Lossnitzer A; Laniado M; Wirth MP
    Urol Oncol; 2013 Oct; 31(7):985-9. PubMed ID: 22093763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
    Siefker-Radtke AO
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
    [No Abstract]   [Full Text] [Related]  

  • 15. Open clinical uro-oncology trials in Canada.
    Winquist E; Rodrigues G
    Can J Urol; 2012 Apr; 19(2):6232-7. PubMed ID: 22512973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Follow-up of urological tumor treatment].
    Ohlmann CH; Albers P; Boehm K; Graefen M; Hakenberg OW; Kuczyk M; Graf J; Peters I; Protzel C
    Urologe A; 2015 Sep; 54(9):1223-33. PubMed ID: 26246111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for immune biomarkers for treatment prognosis and response in genitourinary malignancies.
    Slovin SF
    Biomark Med; 2017 Dec; 11(12):1149-1159. PubMed ID: 29186979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimizing treatment of advanced urologic malignancies].
    Heidenreich A; Ohlmann CH; Ozgür E; Pfister D; Sahi D; Thüer D; Engelmann UH
    Urologe A; 2007 Sep; 46(9):1278-84. PubMed ID: 17628781
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy for urologic cancer.
    Sanda MG; Simons JW
    Urology; 1994 Oct; 44(4):617-24. PubMed ID: 7524239
    [No Abstract]   [Full Text] [Related]  

  • 20. Open clinical uro-oncology trials in Canada.
    Winquist E; Mackenzie MJ; Rodrigues G
    Can J Urol; 2009 Oct; 16(5):4875-81. PubMed ID: 19796473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.